FDA Panel Rejects Bid to Broaden Beta Blocker Indication

MedPage Today -- A cardiovascular advisory panel has unanimously agreed that the FDA should not expand the indications for the beta blocker nebivolol (Bystolic) to include treatment of heart failure in older patients.